Precision Biomarker Resources, Inc. Company Profile

14:41 EDT 24th June 2018 | BioPortfolio

Precision accelerates its clients’ research and drug development by working closely with them on targeted biomarker discovery services, including microarray processing, experimental design consultation and data analysis. The team’s expertise, both scientific and technical, enhances every stage of the process, from discovery through preclinical, clinical and post-market studies. The laboratory is based in Evanston, Illinois, north of Chicago.


820 Davis Street, Suite 216
United States of America


Phone: 847-866-0406
Fax: 847-866-1877

News Articles [643 Associated News Articles listed on BioPortfolio]

No Silver-Bullet Biomarker for Precision RCC Care

Bryant FurlowJun 2, 2018No one molecular biomarker is likely to guide treatment of RCC in the foreseeable future. Multipredictor models might be a way forward, an expert concluded.

Cancer Patients are Relatively Unaware of the Role of Precision Cancer Medicine, Genomics and Biomarker Testing

By Charles H. Weaver, MD CancerConnect News: Precision cancer medicines and the companion tests used to identify them are increasingly […] The post Cancer Patients are Relatively Unaware of the ...

Patients With NSCLC Are Not Undergoing Biomarker Testing for Precision Medicines-Patient Education is Key

Despite guidelines recommending testing, patients with stage IV non-small cell lung cancer (NSCLC) who are treated in the community setting […] The post Patients With NSCLC Are Not Undergoing Bi...

New Thermo Fisher Center Offers Access to Precision Medicine Technologies, Expertise

BOSTON—Thermo Fisher Scientific has opened its U.S. Precision Medicine Science Center (PMSC) in neighboring Cambridge, MA, with a focus on advancing the company’s precision medicine efforts with c...

Personalizing prevention

PlaqueTec plans to bring precision medicine to cardiovascular prevention with a catheter technology that enables biomarker discovery.

Precision Medicine and Public Health: Improving Health Now While Generating New Knowledge for the Future

June 2015 Precision Medicine and Public Health: Improving Health Now While Generating New Knowledge for the Future There is no doubt that the time is right for a large precision medicine coh...

Precision for Medicine erweitert seine Dienstleistungen in Europa und kündigt die nächste ...

An vorderster Front der Präzisionsmedizin steht die Biomarker-Forschung, die für die Entwicklung innovativer Behandlungsmethoden von entscheidender Bedeutung ist, einschließlich der Vorhersage re...

Critical Path Institute receives regulatory support for liver injury biomarker

(Critical Path Institute (C-Path)) The European Medicines Agency (EMA) issued a Letter of Support to C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium for measur...

Drugs and Medications [61 Associated Drugs and Medications listed on BioPortfolio]

Loperamide hydrochloride [Precision Dose Inc.]


Childrens acetaminophen [Precision Dose Inc.]


Childrens cetirizine hydrochloride [Precision Dose Inc.]


Oxygen [Med Resources, Inc.]


Childrens ibuprofen [Precision Dose Inc.]


PubMed Articles [1304 Associated PubMed Articles listed on BioPortfolio]

Computer-aided biomarker discovery for precision medicine: data resources, models and applications.

Biomarkers are a class of measurable and evaluable indicators with the potential to predict disease initiation and progression. In contrast to disease-associated factors, biomarkers hold the promise t...

Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience.

Precision treatment of cancer uses biomarker-driven therapy to individualize and optimize patient care.

Advancing translational research and precision medicine with targeted proteomics.

Remarkable advances in quantitative mass spectrometry have shifted the focus of proteomics from the characterization of protein expression profiles to detailed investigations on the spatial and tempor...

Precision oncology in the era of radiogenomics: the case of D-2HG as an imaging biomarker for mutant IDH gliomas.

Urine biomarkers in the early stages of diseases: current status and perspective.

As a noninvasive and easily available biological fluid, the urine is becoming an important source for disease biomarker study. Change is essential for the usefulness of a biomarker. Without homeostasi...

Clinical Trials [2585 Associated Clinical Trials listed on BioPortfolio]

Instrument Precision Study for Validation of Philips Dx

The objective of this study is to evaluate precision of the Philips Dx system.

Dendritic Cell-precision T Cell for Neo-antigen in the Treatment of Advanced Biliary Tract Malignant Tumor

Objectives: The purpose of this study is to evaluate the safety and prognosis of dendritic cell-precision T cell for neo-antigen in the treatment of advanced biliary tract malignant ...

Validation of Sensitivity and Specificity of a Multi-Omic Precision Diagnostic for Acute Stroke Evaluation

CereDx has early proof of concept clinical data of a multi-omic peripheral blood biomarker profile that can be used to determine stroke from no stroke in the emergency setting. The objecti...

Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD): Improving Targeting Precision

When comparing targeting precision between DBS in parkinsonian patients and OCD patients, an unexpected deviation from the planned targets was discovered in OCD patients (Nuttin et al., 20...

Surefire Precision Infusion System Registry

This project involves the collection and analysis of retrospective and prospective data on patients diagnosed with hepatocellular carcinoma (HCC) in which the Surefire Precision Infusion S...

Companies [1352 Associated Companies listed on BioPortfolio]

Precision Biomarker Resources, Inc.

Precision accelerates its clients’ research and drug development by working closely with them on targeted biomarker discovery services, including microarray processing, experimental design consultat...

Powering Precision Health

The official sponsors partnering with the summit to bring precision health technologies to the forefront of medicine include premier sponsor Quanterix, the leading company digitiz...

ABL, Inc. and Aushon BioSystems

Aushon BioSystems, Inc. is leading the way in protein biomarker discovery, development and analysis. Through the unique combination of proprietary microarray printing, extensive b...


BiomarkerBase™ ( includes every molecular biomarker on a drug label, every biomarker in a PMA-approved diagnostic, prognostic, or companion diagn...

Precision Spine, Inc.

Precision Spine, Inc. is a privately held company with its executive headquarters in Parsippany, NJ. Precision Spine is the parent company of its wholly owned subsidiaries, Spinal...

More Information about "Precision Biomarker Resources, Inc." on BioPortfolio

We have published hundreds of Precision Biomarker Resources, Inc. news stories on BioPortfolio along with dozens of Precision Biomarker Resources, Inc. Clinical Trials and PubMed Articles about Precision Biomarker Resources, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Precision Biomarker Resources, Inc. Companies in our database. You can also find out about relevant Precision Biomarker Resources, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record